NEW YORK (GenomeWeb News) – MDxHealth today said that it has raised €18 million ($23.6 million) through a private placement of new shares.

The Liege, Belgium-based molecular diagnostics developer said that it issued 8,737,683 shares at a price of €2.06 per share, the average closing price of the firm's shares on the NYSE Euronext market during the 30 preceding calendar days.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.